Literature DB >> 26892719

Mouse tissue distribution and persistence of the food-born fusariotoxins Enniatin B and Beauvericin.

Yelko Rodríguez-Carrasco1, Daniela Heilos2, Lennart Richter3, Roderich D Süssmuth3, Petra Heffeter4, Michael Sulyok5, Lukas Kenner6, Walter Berger7, Rita Dornetshuber-Fleiss8.   

Abstract

The fusariotoxins Enniatin B (Enn B) and Beauvericin (Bea) have recently aroused interest as food contaminants and as potential anticancer drugs. However, limited data are available about their toxic profile. Aim of this study was to investigate their pharmacological behavior in vivo and their persistence in mice. Therefore, liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to analyze the distribution of Enn B and Bea in selected tissue samples and biological fluids originating from mice treated intraperitoneally with these cyclohexadepsipeptides. Overall, no toxicological signs during life time or pathological changes were observed. Moreover, both fusariotoxins were found in all tissues and serum but not in urine. Highest amounts were measured in liver and fat demonstrating the moleculeś tendency to bioaccumulate in lipophilic tissues. While for Bea no metabolites could be detected, for Enn B three phase I metabolites (dioxygenated-Enn B, mono- and di-demethylated-Enn B) were found in liver and colon, with dioxygenated-Enn B being most prominent. Consequently, contribution of hepatic as well as intestinal metabolism seems to be involved in the overall metabolism of Enn B. Thus, despite their structural similarity, the metabolism of Enn B and Bea shows distinct discrepancies which might affect long-term effects and tolerability in humans.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Beauvericin; Enniatin B; In vivo; LC-MS/MS; Metabolism

Mesh:

Substances:

Year:  2016        PMID: 26892719      PMCID: PMC5850989          DOI: 10.1016/j.toxlet.2016.02.008

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  38 in total

Review 1.  Fungal cyclooligomer depsipeptides: from classical biochemistry to combinatorial biosynthesis.

Authors:  Roderich Süssmuth; Jane Müller; Hans von Döhren; István Molnár
Journal:  Nat Prod Rep       Date:  2010-10-20       Impact factor: 13.423

Review 2.  Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.

Authors:  Alaa-Eldin F Nassar; Amin M Kamel; Caroline Clarimont
Journal:  Drug Discov Today       Date:  2004-12-01       Impact factor: 7.851

3.  Induction of calcium influx from extracellular fluid by beauvericin in human leukemia cells.

Authors:  Bing-Fang Chen; Meng-Chao Tsai; Guey-Mei Jow
Journal:  Biochem Biophys Res Commun       Date:  2005-12-07       Impact factor: 3.575

4.  Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum.

Authors:  Lada Ivanova; Eystein Skjerve; Gunnar S Eriksen; Silvio Uhlig
Journal:  Toxicon       Date:  2006-03-27       Impact factor: 3.033

5.  Optimization and validation of a quantitative liquid chromatography-tandem mass spectrometric method covering 295 bacterial and fungal metabolites including all regulated mycotoxins in four model food matrices.

Authors:  Alexandra Malachová; Michael Sulyok; Eduardo Beltrán; Franz Berthiller; Rudolf Krska
Journal:  J Chromatogr A       Date:  2014-08-17       Impact factor: 4.759

Review 6.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 7.  Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma.

Authors:  Karen M VanderMolen; William McCulloch; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2011-05-18       Impact factor: 2.649

Review 8.  Improving the decision-making process in structural modification of drug candidates: reducing toxicity.

Authors:  Alaa-Eldin F Nassar; Amin M Kamel; Caroline Clarimont
Journal:  Drug Discov Today       Date:  2004-12-15       Impact factor: 7.851

9.  An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats.

Authors:  Li Mei; Lixin Zhang; Renke Dai
Journal:  J Enzyme Inhib Med Chem       Date:  2009-06       Impact factor: 5.051

Review 10.  Cytochrome P450 pharmacogenetics and cancer.

Authors:  C Rodriguez-Antona; M Ingelman-Sundberg
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

View more
  16 in total

1.  Beauvericin alters the expression of genes coding for key proteins of the mitochondrial chain in ovine cumulus-oocyte complexes.

Authors:  Fiorenza Minervini; Maria Elena Dell'Aquila; Antonella Mastrorocco; Elena Ciani; Luigi Nicassio; Bernard A J Roelen
Journal:  Mycotoxin Res       Date:  2020-09-26       Impact factor: 3.833

2.  Effect of Fusarium-Derived Metabolites on the Barrier Integrity of Differentiated Intestinal Porcine Epithelial Cells (IPEC-J2).

Authors:  Alexandra Springler; Galina-Jacqueline Vrubel; Elisabeth Mayer; Gerd Schatzmayr; Barbara Novak
Journal:  Toxins (Basel)       Date:  2016-11-19       Impact factor: 4.546

3.  Development and Validation of a LC-ESI-MS/MS Method for the Determination of Alternaria Toxins Alternariol, Alternariol Methyl-Ether and Tentoxin in Tomato and Tomato-Based Products.

Authors:  Yelko Rodríguez-Carrasco; Jordi Mañes; Houda Berrada; Cristina Juan
Journal:  Toxins (Basel)       Date:  2016-11-11       Impact factor: 4.546

Review 4.  A Review of the Mycotoxin Enniatin B.

Authors:  Alessandra Prosperini; Houda Berrada; María José Ruiz; Francesca Caloni; Teresa Coccini; Leon J Spicer; Maria Chiara Perego; Alessandra Lafranconi
Journal:  Front Public Health       Date:  2017-11-16

Review 5.  Studies on the Presence of Mycotoxins in Biological Samples: An Overview.

Authors:  Laura Escrivá; Guillermina Font; Lara Manyes; Houda Berrada
Journal:  Toxins (Basel)       Date:  2017-08-18       Impact factor: 4.546

6.  The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study.

Authors:  Daniela Heilos; Yelko Rodríguez-Carrasco; Bernhard Englinger; Gerald Timelthaler; Sushilla van Schoonhoven; Michael Sulyok; Simon Boecker; Roderich D Süssmuth; Petra Heffeter; Rosa Lemmens-Gruber; Rita Dornetshuber-Fleiss; Walter Berger
Journal:  Toxins (Basel)       Date:  2017-08-24       Impact factor: 4.546

7.  Isolation, characterization and toxicological potential of Alternaria-mycotoxins (TeA, AOH and AME) in different Alternaria species from various regions of India.

Authors:  Mukesh Meena; Prashant Swapnil; R S Upadhyay
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 8.  Fusarium Molds and Mycotoxins: Potential Species-Specific Effects.

Authors:  Alessia Bertero; Antonio Moretti; Leon J Spicer; Francesca Caloni
Journal:  Toxins (Basel)       Date:  2018-06-15       Impact factor: 4.546

9.  Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib.

Authors:  Bernhard Englinger; Anna Laemmerer; Patrick Moser; Sebastian Kallus; Clemens Röhrl; Christine Pirker; Dina Baier; Thomas Mohr; Laura Niederstaetter; Samuel M Meier-Menches; Christopher Gerner; Lisa Gabler; Johannes Gojo; Gerald Timelthaler; Julia Senkiv; Walter Jäger; Christian R Kowol; Petra Heffeter; Walter Berger
Journal:  Int J Cancer       Date:  2020-03-02       Impact factor: 7.396

10.  Dispersive Solid-Phase Extraction using Magnetic Carbon Nanotube Composite for the Determination of Emergent Mycotoxins in Urine Samples.

Authors:  Natalia Arroyo-Manzanares; Rosa Peñalver-Soler; Natalia Campillo; Pilar Viñas
Journal:  Toxins (Basel)       Date:  2020-01-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.